Masimo (NASDAQ:MASI) Sets New 12-Month Low – What’s Next?

Masimo Corporation (NASDAQ:MASI)’s share price hit a new 52-week low on Tuesday . The company traded as low as $133.11 and last traded at $134.13, with a volume of 225477 shares. The stock had previously closed at $137.40.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. BTIG Research boosted their price objective on Masimo from $198.00 to $200.00 and gave the company a “buy” rating in a research report on Thursday, December 4th. Wells Fargo & Company restated an “overweight” rating and set a $190.00 price target on shares of Masimo in a research report on Friday, December 5th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Monday, December 1st. Weiss Ratings restated a “sell (d)” rating on shares of Masimo in a report on Wednesday, October 8th. Finally, Wall Street Zen upgraded Masimo from a “hold” rating to a “buy” rating in a research report on Tuesday, October 14th. Four research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $189.40.

Masimo Stock Down 3.0%

The company has a quick ratio of 1.92, a current ratio of 2.84 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $7.15 billion, a P/E ratio of -12.64, a PEG ratio of 1.50 and a beta of 1.26. The firm has a 50-day moving average price of $145.09 and a two-hundred day moving average price of $151.28.

Masimo (NASDAQ:MASI) last released its quarterly earnings data on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter. The business had revenue of $617.00 million for the quarter. Masimo had a positive return on equity of 33.04% and a negative net margin of 33.20%. Equities research analysts anticipate that Masimo Corporation will post 4.1 EPS for the current fiscal year.

Institutional Trading of Masimo

Several institutional investors have recently made changes to their positions in MASI. Twin Tree Management LP bought a new stake in Masimo in the first quarter valued at about $29,000. MAI Capital Management grew its stake in shares of Masimo by 176.7% in the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 129 shares during the period. Hilltop National Bank bought a new position in shares of Masimo during the 2nd quarter worth approximately $37,000. Smartleaf Asset Management LLC grew its position in Masimo by 80.0% in the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 136 shares during the period. Finally, Advisory Services Network LLC bought a new position in shares of Masimo during the third quarter valued at $46,000. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.